Yoo, J.; Choi, Y.; Park, S.A.; Seo, J.Y.; Ahn, C.W.; Han, J.
Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes. J. Clin. Med. 2022, 11, 2327.
https://doi.org/10.3390/jcm11092327
AMA Style
Yoo J, Choi Y, Park SA, Seo JY, Ahn CW, Han J.
Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes. Journal of Clinical Medicine. 2022; 11(9):2327.
https://doi.org/10.3390/jcm11092327
Chicago/Turabian Style
Yoo, Jeongseon, Youngah Choi, Shin Ae Park, Ji Yeon Seo, Chul Woo Ahn, and Jaehyun Han.
2022. "Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes" Journal of Clinical Medicine 11, no. 9: 2327.
https://doi.org/10.3390/jcm11092327
APA Style
Yoo, J., Choi, Y., Park, S. A., Seo, J. Y., Ahn, C. W., & Han, J.
(2022). Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes. Journal of Clinical Medicine, 11(9), 2327.
https://doi.org/10.3390/jcm11092327